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Abstract
Amyloidogenic neurodegenerative diseases are incurable conditions with high social impact that are typically caused by
specific, largely disordered proteins. However, the underlying molecular mechanism remains elusive to established
techniques. A favored hypothesis postulates that a critical conformational change in the monomer (an ideal therapeutic
target) in these ‘‘neurotoxic proteins’’ triggers the pathogenic cascade. We use force spectroscopy and a novel
methodology for unequivocal single-molecule identification to demonstrate a rich conformational polymorphism in the
monomer of four representative neurotoxic proteins. This polymorphism strongly correlates with amyloidogenesis and
neurotoxicity: it is absent in a fibrillization-incompetent mutant, favored by familial-disease mutations and diminished by a
surprisingly promiscuous inhibitor of the critical monomeric b-conformational change, neurotoxicity, and neurodegener-
ation. Hence, we postulate that specific mechanostable conformers are the cause of these diseases, representing important
new early-diagnostic and therapeutic targets. The demonstrated ability to inhibit the conformational heterogeneity of these
proteins by a single pharmacological agent reveals common features in the monomer and suggests a common pathway to
diagnose, prevent, halt, or reverse multiple neurodegenerative diseases.
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Introduction
Amyloid-related neurodegenerative diseases are incurable disor-
ders that are currently classified as conformational diseases (a subset
of the proteinopathies). These diseases are thought to be primarily
caused by an unknown conformational change in specific proteins,
termed ‘‘neurotoxic proteins’’ (NPs), which confers them a cytotoxic
gain of function. This initial transition in the soluble monomer
triggers a series of events that lead to the formation of small soluble
oligomers and protofibrils, and ultimately the generation of highly
ordered fibrillar insoluble aggregates. More than 20 of these NPs
have been found to be intrinsically disordered proteins (IDPs).
Despite the fact that the monomers of NPs have different primary
and, when folded, tertiary structures, their oligomers and aggregates
share common structural properties [1,2], including recognition by
a conformational antibody [3]. Whereas the nature of the cytotoxic
species and the molecular mechanisms involved in their misfolding
and aggregation remain largely unknown, there is growing evidence
that conformational changes preceding aggregation are fundamen-
tal in the molecular pathogenesis of these diseases [1]. Furthermore,
as the formation of monomeric misfolding intermediates is regarded
as the earliest event in the pathogenic cascade, this process
represents an ideal therapeutic target [4].
Remarkably, it was recently demonstrated that the key
conformational change that endows amyloidogenesis occurs in
the monomer, triggering aggregation and fibrillogenesis as well as
cytotoxicity [5–7]. Thus, to understand the acquisition of toxic
properties by NPs, the three-dimensional structure of this toxic
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monomeric conformer must be characterized. However, the
propensity of monomers to aggregate in vitro hampers their
structural analysis using classical high resolution techniques such
as X-ray crystallography or solution nuclear magnetic resonance
(NMR). Nevertheless, it was shown that some NPs are rich in a-
helical [8,9] or disordered [10,11] segments. It must be noted that
the oligomeric state of a-synuclein, the NP associated to Parkinson
disease, remains controversial. Thus, while some reports validate it
as a natively unfolded monomer [12], other studies have shown,
interestingly, that its potential native state is a dynamic a-helical
tetramer [13,14] that undergoes unfolding/folding cycles associ-
ated to its physiological function to promote SNARE complex
formation in neurons [15]. Furthermore, it was suggested that
many alternative monomeric conformations may coexist in a
dynamic equilibrium that progressively shifts toward conformers
enriched in b-structure, which are thought to be the first toxic
species [2]. However, the inherent ensemble averaging of these
techniques prevents the full complexity of monomer conforma-
tional equilibria from being elucidated and the fast fluctuations
involved from being resolved. Moreover, solid-state NMR and X-
ray crystallography can only provide structural information about
the final species (i.e., amyloid fibers [16]).
Bulk-based, theoretical, and single-molecule studies support the
existence of conformational heterogeneity in intrinsically disor-
dered NPs [1,17,18]. However, the co-existence of several species
in solution at equilibrium, some of which may be scarcely
populated, makes analyzing IDPs a particularly challenging task
using established biophysical techniques [19]. By contrast, single-
molecule techniques provide a unique opportunity to tackle this
problem being able to reveal monomeric conformers [18]. Some
of these techniques have already been used to monitor the activity
and conformation of proteins with conformational plasticity [20],
resolving fast fluctuations (20–300 ns) at the monomeric level [21].
Of the available techniques, nanomanipulation has two additional
advantages. First, it allows the forces involved in stabilization of
the intramolecular interactions to be directly measured (mechan-
ical stability); and second, it enables the mechanical stability of a
protein to be related with its conformation. In particular, atomic
force microscopy (AFM)-based single-molecule force spectroscopy
(SMFS, for short) shows remarkable potential to analyze the
conformational equilibrium of monomers, and even to detect low-
abundant conformers [18]. In principle, measuring the mechan-
ostability of NPs using SMFS should be feasible, as the toxic gain
of function of NPs parallels the acquisition of b-structure [1,2], a
secondary structure that is usually detectable and is often more
mechanostable (M) than a-helical or disordered (random coil
[RC]) conformations [22]. Furthermore, determining the mechan-
ostability of NPs is particularly relevant, given their processing by
chaperones and chaperone-related proteases [23], which unfold
their substrates mechanically using AAA+ ATPase molecular
motors [24,25].
Previous SMFS studies of NPs [26–29] have been hindered by
three serious problems. Firstly, standard polyproteins were used as
single-molecule markers fused to the NP, and since the NP is
placed in series with the marker repeats, the SMFS recordings
obtained are typically contaminated in the proximal region
(Figure 1), thereby compromising the reliability of the data
obtained. Secondly, the amyloidogenic behavior of the NP fused to
the polyprotein was not demonstrated. Finally, there is no
convincing evidence demonstrating that the selected data origi-
nated from bona fide intramolecular interactions (rather than
intermolecular interactions). In the present study, these limitations
have been overcome to reveal the existence of a rich conforma-
tional polymorphism in the monomer of NPs and to demonstrate
its link to amyloidogenesis and neurotoxicity (Figure S1).
Results
Unequivocal Single-Molecule Analysis and Controls for
Structure and Amyloidogenesis
To circumvent the first of the aforementioned limitations, we
recently developed a novel strategy that uses a new vector to
mechanically protect the NP as a guest inside a carrier protein of
well-known mechanical properties (plasmid for force spectroscopy-
2 [pFS-2]) (Figure 1A) [30]. Accordingly, unlike previous works
[26], by means of this approach (termed the ‘‘carrier-guest’’
strategy) the SMFS data obtained from the NP are always read
after the unfolding of the carrier, far from the proximal region to
the AFM substrate, which is known to be typically noisy and thus
unreliable (Figure 1B; Text S1). We used SMFS to analyze the
nanomechanics of NPs expressed as fusion polyproteins in pFS-2.
Using the so-called length-clamp mode of this technique, two basic
parameters are directly obtained (see Text S1): the mechanical
stability of the resistance barriers (F, measured directly by the
height of the force peaks in a force-extension recording), and the
length released after unfolding (increase in contour length (DLc) as
measured by fitting the force-extension recording to the worm-like
chain [WLC] model of polymer elasticity). We followed highly
stringent criteria when selecting single-molecule recordings using
the carrier-guest mechanical protection strategy whereby we only
selected those recordings in which the DLc of the carrier (alone or
including a non-mechanostable fraction from the NP) was
followed, although not necessarily consecutively [29], by force
peaks with DLc values that accounted for the total expected length
released by the carrier-guest protein (Figure 1B; Text S1).
This strategy was employed to study four model NPs: three
human NPs (expanded poly-glutamines -polyQ-, b-amyloid1–42 -
Ab42-, and a-synuclein) and a neurotoxic-like protein that has
been extensively used as a model for human prions (Sup35NM, a
yeast prion). These NPs are amyloidogenic IDPs [18], and they are
thought to cause the most representative neurodegenerative
diseases: polyQ (familial disorders such as Huntington’s disease),
Alzheimer’s, Parkinson’s, and prion diseases, respectively [1,18].
All these NPs, including Ab [31], are found intracellularly, and
Author Summary
Neurodegenerative diseases like Alzheimer’s or Parkinson’s
are currently incurable. They are caused by different
proteins that, under certain circumstances, aggregate and
become toxic as we grow older, but the molecular events
underlying this process remain unclear. The lack of a well-
defined structure, and the tendency of these ‘‘neurotoxic
proteins’’ to aggregate make them difficult to study using
conventional techniques. Here, we use an established
single-molecule manipulation technique combined with a
new protein-engineering strategy to show that all these
proteins can adopt a rich collection of structures
(conformers) that includes a high proportion of mechano-
stable conformers, which are associated with toxicity and
disease. We also find that a known drug can block the
formation of these mechanostable structures in different
neurotoxic proteins. We suggest that the most mechano-
stable conformers, or their precursors, may trigger the
pathogenic cascade that results in toxicity. We thus
propose that these mechanostable structures are ideal
targets for early diagnosis, prevention, and treatment of
these fatal diseases.
Nanomechanics of Neurotoxic Proteins
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they are therefore susceptible to be stretched by the protein-
processing machinery [23].
To test whether the properties of these engineered NPs and
carriers are preserved in the carrier-guest proteins (the second
limitation of the former SMFS studies listed above), we performed
standard structural, calorimetric, and fibrillogenic experiments on
the isolated carrier-guest proteins (Figures S2, S3, S4, S5, S6, S7,
S8, S9; Table S1; Text S1). Whereas the conformational stability
of the carrier proteins is reduced when they contain the guest NP,
and in some preparations some molecules even lose their folded
tertiary structure, the carriers essentially maintain their structure
and mechanical properties (Table S2), which enables the
unambiguous observation of the conformational polymorphism
of the monomeric NPs. Furthermore, regarding the possible
presence of spurious interactions, in these studies we found no
evidence of contacts or other interactions between the carrier and
guest proteins beyond the covalent linkage of the polypeptide
chain. This rules out the possibility of artifactual contacts, and
hence a possible gain of structure, induced in the NPs when nested
inside the carriers or the other way around.
To the best of our knowledge, the pFS-2 vector is the first
strategy capable of successfully avoiding the contamination of
SMFS data with non-specific interactions from the proximal
region of the AFM, which is particularly useful for studying IDPs
[30]. Indeed, this approach guarantees that the selected data
originate from the stretching of single NP molecules (Figure 1).
However, in principle, the stretching of a single NP monomer does
not exclude possible interactions of the NP with the carrier, the
AFM elements (substrate or tip) or other surrounding NPs
(intermolecular interactions from oligomers and/or fibers). Such
potential interactions (the third limitation of those SMFS studies
listed above) must be ruled out before force events can be
unequivocally attributed to intramolecular interactions in the NP
monomers. By using specific controls, we provide compelling
evidence that in our experimental conditions, the stringently
selected SMFS data (we sampled about 100 molecules of each NP
with each set of recordings resulting from 50,000–100,000 pulling
attempts) exclusively arose from monomeric NPs and, therefore,
represent bona fide intramolecular interactions (Text S1).
Finally, by restricting the degrees of freedom of the hosted NPs,
the pFS-2 strategy has the additional advantage of dramatically
slowing down fibrillogenesis (Figure S6D; Text S1), thereby
minimizing the formation of aggregates, during the nanomecha-
nical analysis of the monomeric NPs.
Figure 1. Nanomechanical analysis of NPs using the pFS-2 strategy. (A) Top: Schematic representation of the pFS-2 polyprotein [30] carrying
a guest NP (in orange) mechanically protected within a carrier module (C, in gray), flanked by ubiquitin repeats (U, in black). Bottom: cartoon
representations of the two carrier-guest constructions used in this study: ubiquitin (left, PDB code 1d3z) and titin I27 (right, PDB code 1tit). The
images were prepared by VMD 1.8.6 [58]. The hydrogen bonds of the mechanical clamp in both carriers are indicated by black bars [51]. (B)
Representative force-extension recordings of pFS-2+Sup35NM. Using this strategy, we can unambiguously resolve a variety of conformations
adopted by Sup35NM, ranging from a typical NM conformation (top trace, in orange), to M conformations with different degrees of mechanical
stability (in red), including hM conformers (bottom). This color code will be maintained throughout the rest of the article. On the basis of our carrier-
guest design, the carrier module must always unfold completely (‘‘a’’ is DLc for the carrier module) before the force can access and stretch the guest
NP, resulting in its unfolding (‘‘b’’ and ‘‘c’’ represent the DLc for NM and M regions of the NP, respectively). The sum of b+c corresponds to the
complete unfolding of the NP. The pFS-2 vector also contains an NM region, represented as a coil (a fragment of titin N2B [30]) that can act as a
spacer to avoid the noisy proximal region of the force-extension recordings, a major problem in SMFS.
doi:10.1371/journal.pbio.1001335.g001
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Conformational Polymorphism of NPs
PolyQ diseases are unique among amyloidogenic neurodegen-
erative diseases in that they are both genetically determined and
their NPs, polyQ expansions, have pathological thresholds (21–30
and 36–40 glutamine residues in spinocerebellar ataxia type 6
[SCA6] and Huntington disease, respectively). Interestingly, there
is a positive correlation between the number of glutamine repeats
and the severity of the disease, the age of onset, and the
oligomerization kinetics [4,32]. Thus, in the simplest hypothesis,
the disease determinants are expected to correlate with the
number of glutamine residues. Using SMFS we looked for possible
mechanical differences in the monomeric polyQ tracts of three
lengths that are considered to be sub-, near- (except for SCA6) and
super-threshold for triggering polyQ diseases: Q19, Q35, and Q62
(Figure 2A). We found that the subthreshold tract showed no force
peaks; we term these conformers ‘‘non-mechanostable’’ (NM) (i.e.,
there were no detectable SMFS conformations; the force detection
limit of SMFS was taken as twice the force error, 20 pN, at a
pulling speed of 0.4 nm/ms) (Figure 2A, orange bars; this
representation is followed also in Figures 3–5; Text S1). Similar
mechanical behavior was observed for non-amyloidogenic/non-
neurotoxic IDPs [33,34], including VAMP2 (Figure 2B) [35].
Accordingly, neither Q19 nor VAMP2 constructs produced
amyloidogenesis (Figures 2, S2C, S2D, S3C, and S3D).
By contrast, Q35, which showed moderate amyloidogenesis
(Figure S2C and S2D), exhibited not only numerous NM
conformations (F#20 pN) but also several force peaks with a
variety of DLc values; we call these conformers ‘‘mechanostable’’
(M) (F.20 pN) (Figure 2A, red bars). DLc and F were found to be
uncorrelated (Figure S10A) as recently reported for the NP tau
[29]. Interestingly, this incipient conformational polymorphism
included conformers with extremely high mechanical stability
(F$400 pN). Given that the mechanical stability (upon N-C
stretching) of eukaryotic proteins studied to date is below 400 pN
[22], we have operationally defined an additional subset in the
latter class based on an arbitrary force value of 400 pN. This
subset of M conformers that accounts for events with F$400 pN
(which are rare) is termed hyper-mechanostable (hM).
Figure 2. Nanomechanical analysis of polyQ tracts and a non-amyloidogenic IDP (VAMP2). (A) DLc (left) and F (right) histograms for pFS-2
polyproteins carrying polyQ tracts. The sub-threshold Q19 (front row) only shows NM conformers (orange bars; represented in the force histograms
below the force sensitivity of our AFM: F,20 pN). Familial-disease mutations of this protein (expanded polyQs: Q35 and Q62) exhibit conformational
polymorphism that ranges from NM conformers to M conformers (red bars), the latter class including some hM conformers (F$400 pN, i.e., likely toxic
conformers according to our hypothesis, see text). It should be noted that the longer the polyQ tract, the greater the conformational polymorphism
and the more hM conformers found. The inhibitor QBP1 (20 mM [42]) reduces this polymorphism and abolishes the hM conformers. The inset shows
an example of a hM conformer of Q62. Note that the hM class of conformers is a subset of the M set so that the percentage of hM conformers (respect
to the total number of molecules sampled, n) is included into that of M (this also applies to the remainder main figures of this work as well as to
Table 1). TEM images of the amyloid fibers formed by the corresponding carrier-guest proteins (not the whole pFS polyprotein) are shown on the
right, highlighting the relationship between hM conformers and amyloidosis. From bottom to top, the scale bars correspond to 0.6, 0.3, 0.3, and
0.6 mm, respectively. (B) SMFS analysis of pFS-2+VAMP2. This non-amyloidogenic IDP [35] does not show conformational polymorphism. The scale bar
from the TEM image on the right corresponds to 0.6 mm. Only data from the guest protein, and not from the carrier, are plotted in the histograms
presented in this figure and Figures 3–5.
doi:10.1371/journal.pbio.1001335.g002
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Based on our current knowledge of NPs [1] and recent studies of
polyQ tracts [5], it is likely that NM and M conformers correspond
to RC and b-stranded structures, respectively (see Text S1), as has
been previously assumed [26,27]. Together, these results indicate
that polyQ tracts of 35 glutamines can experience a structural
transition that permits conformational fluctuations. Significantly,
Q62 exhibited even greater conformational polymorphism that
also included a higher number of hM conformers (Figure 2A).
Thus, expanded polyQ tracts (Q35 and Q62) allow the appearance
of conformations that can be detected by SMFS; these mechanical
conformations include hM conformers. This polymorphism
(estimated as the frequency of M conformers, including hM ones)
Figure 3. Nanomechanical analysis of Ab42. DLc (left) and F (right) histograms of pFS-2 polyproteins carrying Ab42. The wt protein (first row)
shows broad polymorphism ranging from NM conformers (orange bars) to M conformers (red bars). No hM conformers were found in this protein.
Incubation of Ab42 with and without SV111 (100 mM [38]) yielded similar results, strongly indicating that our SMFS data reflect unfolding events
originating from different conformations adopted by the monomeric forms of NPs (as opposed to intermolecular interactions of the oligomeric
species). Arc Ab42 (E22G) familial-disease mutation increases the number of M and hM conformers when compared to the wt protein. Incubation
with QBP1 peptide (20 mM [42]) does not impair the formation of M conformers in Arc Ab42. For F19S/L34P Ab42 only NM conformations were
observed despite the larger sample size (Table 1). TEM images of the amyloid fibers formed by the corresponding proteins are shown on the right.
From bottom to top, the scale bars correspond to 0.6, 0.6, 0.45, 0.35, and 0.9 mm, respectively. An example of hM conformer of Arc Ab42 is shown in
the inset.
doi:10.1371/journal.pbio.1001335.g003
Figure 4. Nanomechanical analysis of a-synuclein. DLc (left) and F (right) histograms of pFS-2 polyproteins carrying a-synuclein. The wt protein
(first row) exhibits a wide-range polymorphism ranging from NM conformers (orange bars) to M conformers (red bars), including some hM
conformers. Familial-disease mutations A30P and A53T increase the number of M and hM conformers of a-synuclein when compared to the wt.
Treatment with QBP1 peptide (20 mM [42]) reduces the formation of M and hM conformers in A53T a-synuclein. TEM images of the amyloid fibers
formed by ubi+A53T a-synuclein are shown on the right in which amyloid fibers are clearly not formed in the presence of QBP1 (top image). From
bottom to top, the scale bars correspond to 0.45 and 0.6 mm, respectively. Examples of hM conformers of A30P and A53T a-synuclein are shown in
the inset.
doi:10.1371/journal.pbio.1001335.g004
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is positively correlated with the polyQ length, which in turn
correlates with amyloidogenesis. Interestingly, a structural corre-
lation with the pathological threshold for polyQs has been
previously reported [5].
The SMFS analysis of the three NPs used as models of sporadic
neurodegenerative diseases (Ab42, a-synuclein, and Sup35NM)
[1,2] showed that the wild-type (wt) form of each protein exhibited
a rich conformational polymorphism, which also included rare hM
conformers (except for Ab42) (Figures 3–5). The differences in the
occurrences of stable conformers in NPs relative to non-
amyloidogenic IDPs (VAMP2, Q19, and F19S/L34P Ab42, see
below) are statistically significant (Table 1).
In the wt form of the four model NPs, the frequency of M
conformers ranged from 0% in Q19 (Q21 is the minimum
pathological threshold detected in polyQ diseases, specifically in
SCA6 [2]) to 64% in Sup35NM, which for each NP was positively
correlated with amyloid fiber density (Figures 2–5, S2D, S3D,
S4D, S5D, S6D; Table S1). The frequency of hM conformers for
wt NPs ranged from 0% to 8% (Figures 2–5). These rare events
are associated with extremely high rupture forces (up to
,800 pN), greater than those reported for the most mechano-
stable proteins described to date (i.e., bacterial cohesin modules
[36]) and just below the force range required to break a covalent
bond [37]. Table 1 summarizes the frequency for each conformer
type. Frequently, more than one force peak was found for each NP
molecule (Figure S11), suggesting the presence of more than one
structured region in the M conformers.
It should be noted that the number (and thus the frequency) of
M conformers may in reality be greater than that estimated due to
the existence of additional SMFS curves that could correspond to
incomplete recordings, i.e., compatible with the unfolding of a
carrier bearing a mechanostable element that was not fully
observed probably due to the premature detachment of the
molecule. Although mechanostability is a stochastic property,
these premature detachment events should often be lower than the
forces needed to unravel the undetected NP (putative M
conformers). A subset of these recordings contained putative hM
events (Figure S12). Although these putative events were not
included in the sample size, n, it is interesting to note that there is a
good correlation between the putative and detected hM events
among the different NPs and conditions tested (Table S3).
Taken together, SMFS analysis revealed that whereas VAMP2,
a non-neurotoxic IDP, always shows a low (undetectable)
Figure 5. Nanomechanical analysis of Sup35NM. DLc (left) and F (right) histograms of pFS-2 polyproteins carrying Sup35NM. Like the wt
proteins in Figures 3 and 4, Sup35NM (first row) shows a broad polymorphism, including rare hM conformers. Treatment with QBP1 peptide (20 mM
[42], back row) decreases the formation of M and hM conformers, as seen for both polyQ and a-synuclein (Q62 and A53T, Figures 2 and 4). TEM
images of the amyloid fibers formed by I27+Sup35NM are shown on the right. Addition of QBP1 clearly reduces the formation of amyloid fibers. The
scale bars correspond to 0.6 (top) and 0.4 mm (bottom).
doi:10.1371/journal.pbio.1001335.g005
Table 1. Summary of the nanomechanical analysis of NPs.
Protein n NM (%) M (%) hM (%)
PolyQ Q19 111 100 0 0
Q35 100 95.0 5.0 (4) 1
Q62 2QBP1 107 92.5 7.5 (5) 2.8
+QBP1 124 96.7 3.3 (3) 0
VAMP2 I27-VAMP2 188 100 0 0
Ubi-VAMP2 234 100 0 0
Ab Ab42 2SV111 116 67.2 32.8 (9) 0
+SV111 128 69.8 30.2 (8) 0.8
Arc Ab42 2QBP1 102 37.9 62.1 (10) 1
+QBP1 108 42.6 57.4 (9) 0
F19S/L34P Ab42 396 100 0 0
a-syn wt 98 55.1 44.9 (10) 261
A30P 92 41.0 59.0 (10) 3.3
A53T 2QBP1 96 39.6 60.4 (10) 5.261.0
+QBP1 259 86.5 13.5 (4) 0.4
Sup35NM 2QBP1 100 36.0 64.0 (10) 8
+QBP1 100 73.0 27.0 (9) 1
SMFS experiments were performed on pFS-2 polyprotein constructs, although
the data reported only refer to the guest NPs. The calculation of the associated
experimental errors is described in Text S1 and they are only indicated when
they are different to zero. Due to the small number of events, the frequency of
hM conformers in the NPs (a subset of the M set, operationally defined with a
high F cut off) is not statistically significant. However it correlates very well with
the %M. Furthermore, statistical analysis shows that, with the exception of
polyQ tracts (for which the number of M, events is too low), the differences in
the %M events for NP guests are statistically significant for the following pairs:
NP and non-NP, NP and familial NP, NP (except for Arc Ab42) and NP+QBP1.
These differences are not statistically significant for the following pairs: Ab42
and Ab42+SV111, Arc Ab42 and Arc Ab42+QBP1, and non NPs. The numbers in
parenthesis are half of the 95% confidence interval for the %M (or NM, modeled
as a Bernoulli distribution) while the numbers after 6 are the SMFS
experimental errors. Note that the % numbers here are the estimation for the
population while the % numbers in Figures 2–5 correspond to the raw samples.
n, sample size. NM, no force peaks detected: F#20 pN; M, at least one force
peak: F.20 pN; hM, subset of M conformers with at least one force peak
with F$400 pN.
doi:10.1371/journal.pbio.1001335.t001
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resistance to mechanical unfolding, all the NPs studied behaved
similarly, displaying a high degree of mechanical conformational
polymorphism that often included a few hM conformers. We
postulate that this behavior is associated with amyloidogenesis and
neurotoxicity, which, in agreement with previous results [5],
strongly suggests that a critical conformational change in the
monomer leads to the generation of the first toxic NP species.
Hence, we have tested this working hypothesis by studying four
conditions in which the disease and/or amyloidogenesis are
affected in two ways: diminished with a peptide that blocks the
oligomerization process, an aggregation-defective mutant, or a
peptide that inhibits the b-conformational change; and intensified
by familial-disease mutations. According to our hypothesis, in
these conditions the conformational polymorphism (and hM
frequency) should be unaltered, abolished, decreased, or increased,
respectively.
Oligomerization Inhibition Does Not Alter Polymorphism
We first studied the effect of blocking oligomerization on the
conformational polymorphism of monomeric NPs. Specifically, we
used the SV111 peptide, which inhibits Ab42 oligomerization and
fibrillogenesis by binding to a specific b-hairpin structure [38], but
should not affect the conformational fluctuations of the unbound
monomers. Notably, incubation of Ab42 with SV111 (100 mM
[38]) yielded SMFS results similar to those from the untreated
Ab42, including the number of events per molecule (Figures 3 and
S11; Table 1), whereas fibrillogenesis was inhibited (Figures 3 and
S4D; Table S1). Since this peptide effectively inhibits oligomer-
ization, this experiment also served as a control to rule out a
significant contribution of intermolecular interactions to our
SMFS data, strongly suggesting that the behavior observed
originated from bona fide intramolecular interactions within the
NP monomer (Text S1).
Fibrillogenesis-Defective Mutant Lacks Polymorphism
We then analyzed a double mutant of Ab42 known to suppress
fibrillogenesis (F19S/L34P) [39]. As expected, the results obtained
(Figures 3 and S4) were similar to those obtained with Q19 or
VAMP2 (Figures 2, S2, and S3). This experiment also served as a
control to exclude potential interactions between the NPs and the
AFM elements as a source of the M events (Text S1).
Familial-Disease Mutations Increase Polymorphism
We next studied the effect of additional representative familial
neurodegenerative disease mutations on the conformational
polymorphism, using dominant forms responsible for the early
onset of the disease and for the acceleration of oligomerization
kinetics [1,2]. In addition to Q35 and Q62, we also studied the
arctic (Arc: E22G) mutation in Ab42 that has been implicated in
familial Alzheimer’s disease, as well as the A30P and A53T
mutations in a-synuclein that are involved in familial Parkinsonism
[1,2]. Like the results obtained with Q35 and Q62, we found an
increase in the frequency of M conformers, including hM ones, for
all the mutants analyzed (Figures 3 and 4; Table 1). Similarly, the
number of mechanostable regions (i.e., force peaks) per molecule
increased for each NP mutant studied (Figure S11). Finally, two of
the familial-disease mutations also increased the number of
putative hM recordings (Q62 in polyQ tracts and A53T in a-
synuclein) (Figure S12). Taken together, these results indicate that
familial-disease mutations increase the propensity to form M
conformers, including hM forms, an effect that is correlated with
aggregation and fibrillogenesis, at least for polyQ tracts. This
increased conformational polymorphism may also explain the
dominant character of these NP mutations.
A Promiscuous b-Sheet Blocker Decreases Polymorphism
We finally analyzed how the conformational polymorphism of
NPs was affected by PolyQ-binding peptide 1 (QBP1), an
amyloidosis inhibitor known to block the critical b-conformational
change of expanded polyQs at the monomer level. QBP1 binds
RC conformers [5,40], suppressing oligomerization, amyloidogen-
esis, cytotoxicity [5], and neurodegeneration [41]. Specifically, we
used the minimal active core of this peptide (QBP1-M8) [42].
Incubation of Q62 with QBP1 completely abolished the formation
of fibers (Figures 2 and S2; Table S1), and effectively reduced both
the frequency of detected and putative M conformer formation,
including hM forms (Figures 2, S12B; Tables 1 and S3). The
number of mechanostable events per molecule (Figure S11A) was
also reduced.
In what was originally intended as a negative control
experiment, we also tested the effect of this peptide on the other
three NPs, selecting two well-characterized familial-disease muta-
tions (Arc Ab42 [Figure 3] and A53T a-synuclein [Figure 4]) and
the yeast prion Sup35NM (Figure 5). Surprisingly, QBP1 strongly
diminished the formation of M conformers (detected and putative)
of both A53T a-synuclein and Sup35NM (Figures 4, 5, and S12;
Table S3). The subset of hM conformers (detected and putative)
showed a significant decrease as well (Figure S12; Table S3).
Aggregation and fibrillization were also reduced or suppressed by
QBP1 in these two NPs (Table S1). It should be noted that the
effect of the peptide on Sup35NM was incomplete as some fibers
were still formed (Figures 5 and S6D), while its effect on A53T a-
synuclein was not as significant, given the small number of fibers
formed by this mutant in the absence of the inhibitor (Figures 4
and S5D). Interestingly, in the specific conditions used in our
experiments, QBP1 appeared to have no significant effect on Arc
Ab42, either on the conformational polymorphism or its
aggregation and fibrillization capabilities (Figures 3, S4C, and
S4D; Tables 1 and S1). Furthermore, the frequency of hM events
in the untreated Arc Ab42 was so low (the lowest of the four NPs)
that any apparent effect could not be considered significant. To
rule out any effect of QBP1 on Ab42, higher concentrations of
QBP1 (from 100 mM to 1 mM) were tested on the isolated Ab42
and no effect in fiber formation was observed (Figure S4D).
These results point to the existence of common characteristics at
the monomer level in at least three of the NPs studied (expanded
polyQs, a-synuclein, and Sup35NM), which appear to be
recognized by QBP1. In spite of the similarities found for all the
NPs studied, the inability of QBP1 to recognize Ab42 indicates
that there may be some variation in nascent amyloidogenesis. It
should also be noted that structural characterization as well as
aggregation and fibrillogenesis experiments (Figures S2, S5, and
S6) suggest that the inhibitory effect of QBP1 is stronger on
expanded polyQ tracts than on A53T a-synuclein or Sup35NM,
while it seems not to affect Arc Ab42 (at the same peptide
concentration) (Figure S4), in accordance to its mentioned effect
on the conformational polymorphism. Given that QBP1 blocks the
formation of b-structures [5], it is likely that at least some M
conformers contain such b-structures, as discussed below. These
results extend previous observations of common molecular
mechanisms in both oligomerization and fibrillogenesis on the
basis of the recognition of similar oligomeric structures in all NPs
tested by the A11 conformational antibody [3] and in the existence
of a similar though somewhat variable cross-b spine structure
discovered in these fibers [16,43].
Thus, our results point to the existence of additional common
molecular mechanisms upstream in amyloidogenesis acting in the
initial stages of this process at the monomer level.
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Discussion
Single-molecule techniques are ideal to analyze the conforma-
tional polymorphism of NPs and SMFS in particular is a highly
promising technique that has already been used to this end [26–
29]. However, the disordered nature of NPs and their tendency to
oligomerize pose significant challenges to this kind of analysis. We
have successfully developed a strategy to unequivocally analyze at
the single-molecule level the conformational polymorphism of
IDPs, and in particular NPs. Accordingly, we have sampled the
conformational space with about 100 molecules from each of the
four most representative NPs and their variants: polyQ tracts,
Ab42, a-synuclein and Sup35NM (see Table 1). We demonstrate
that proteins (neurotoxic or not) that do not form amyloid fibers
(i.e., non-pathological polyQ tracts such as Q19, VAMP2, and the
F19S/L34P Ab42 mutant) show no mechanical conformational
polymorphism, as monitored by SMFS. By contrast, proteins with
propensity to form amyloid fibers (expanded polyQs, Sup35NM,
and wt and familial-disease mutations for Ab42 and a-synuclein)
exhibit a rich conformational polymorphism that includes rare hM
conformers.
As mentioned, it is likely that NM and M conformers
correspond to RC and b-stranded structures, respectively. In the
case of prions, conformers separated by a high-energy barrier and
stabilized by strong non-covalent forces (presumably high-density
hydrogen bonding), have recently been proposed to account for
the heritability of conformations [44]. It is tempting to speculate
that these structures may contain b-strands in a shear (rather than
zipper) configuration, as this is the most mechanostable structure
observed experimentally to date [36,45]. These hM conformers
were already suggested in previous SMFS studies of polyQs [28],
although the authors assumed they involved collapsed rather than
b-stranded structures, even for non-pathological tracts. It is
important to emphasize that our SMFS results correlate closely
with our structural and aggregation/fibrillogenesis controls (Table
S1). However, our results are not directly comparable to those of
previous studies, which did not include unequivocal single-
molecule markers, structural controls, or controls for intermolec-
ular interactions. Thus, while our findings are in line with previous
results from tau [29], except that these authors did not report NM
conformers, they diverge significantly from those reported for a-
synuclein [26,27], possibly owing to the larger sample size used for
tau as compared with a-synuclein (214–453 versus 34–63,
respectively).
Neurotoxic and neurotoxic-like proteins involved in sporadic
neurodegenerative diseases (Ab42, a-synuclein, and Sup35NM)
[1,2] exist as a broad ensemble of NM and M conformers,
including a few hM forms. In contrast, Q19 (which fails to trigger
disease) does not show M conformers. These findings and previous
observations [41] strengthen the connection between M conform-
ers, amyloidogenesis, and disease. Indeed, mutations that induce
an early disease onset and accelerate amyloidogenesis [1,2]
increase the frequency of M (and hM) conformers. Conversely,
treatment with the QBP1 inhibitor peptide strongly reduced the
frequency of M (and hM) conformers in A53T a-synuclein and
Sup35NM. Intriguingly, this treatment did not affect the
conformational polymorphism of Arc Ab42. Moreover, incubation
of Ab42 with SV111 yielded a similar conformational polymor-
phism as for the untreated Ab42, although it did inhibit
aggregation and fibrillogenesis, in agreement with previous results
[38].
Overall, we observed an excellent correlation between the
propensity to develop a neurodegenerative disease, previously
demonstrated by others [1,2], and conformational polymorphism,
including hM conformers, of the relevant NPs. We show that this
polymorphism can be altered in both directions, towards more
‘‘structured’’ conformers by pathological mutations or towards the
NM conformation, by the QBP1 inhibitor and by non-fibrillogenic
mutations. The dramatic reduction of the frequency of M
conformers, including hM forms, produced by QBP1 suggests
that hM conformers and/or their precursors from the M pool are
good candidates to represent the primary cause of neurodegen-
erative diseases (i.e., the hypothetical initial misfolded intermedi-
ate). Since QBP1 inhibits the formation of these conformers and
exerts anti-neurodegenerative effect [41], we conclude that hM
conformers, and/or their precursors, are likely on-pathway
intermediates in amyloidogenesis and/or cytotoxicity. The
discovery of these common features offers hope that a single
therapeutic agent may be able to prevent, halt, or reverse the
development of many neurodegenerative diseases arising from
these different proteins.
Prior to our work, it was known that common molecular
mechanisms existed in the later stages of amyloidogenesis,
including oligomerization [3] and amyloid fiber formation [43].
Also, prion-like behavior has been recently shown for polyQ tracts,
Ab and a-synuclein [46]. Our identification of a common pattern
of conformational propensities among the monomers of the four
most representative NPs further extends this unifying view to the
earliest stages of the amyloidogenesis process. Furthermore, the
inhibition of fibrillogenesis by the same peptide in three out of
those four NPs suggest that amyloidogenesis shows common
molecular features from the very beginning of the process,
although some diversity is also likely [16].
In general, our results strongly support the conformational
change hypothesis as the mechanism to explain the initiation of
amyloidogenesis [47], wherein amyloidogenesis is thought to be
preceded and triggered by a conformational change in the
monomer precursor [4]. In the particular case of polyQs (the
clearest-cut system), the nature of the conformational changes that
occur during polyQ amyloidogenesis have remained controversial
[2,4,48]. In fact, other models for polyQ diseases have received
greater attention in the literature, such as the ‘‘polymerization
hypothesis’’ (i.e., the conformational change is induced upon
monomer polymerization into fibers) or recruitment mechanisms
like the ‘‘linear lattice’’ model [2,48]. Our data strongly suggest
that it is the monomer that undergoes the critical conformational
change that results in the generation of the first toxic species [5].
Furthermore, our data provide strong evidence supporting the so-
called ‘‘structural threshold hypothesis,’’ which states that above
the pathological threshold polyQ tracts undergo a structural
transition from RC to b-sheet structure [49] and indicating that it
occurs in the monomer. Our single-molecule approach also
provides an explanation for the failure to detect this change using
NMR spectroscopy in a previous study [50]. M conformers
represent just 7.5% or less of species, a fraction that is difficult to
detect even if all these conformers were from a unique species
(which seems not to be the case according to our DLc data).
Finally, we note that in the aforementioned study the Glutathione
S-transferase-Qn (GST-Qn) fusion proteins used did not show
evidence of aggregation.
We have adopted a new strategy to unequivocally identify and
quantify the conformational polymorphism of NPs and their
pathological and non-pathological variants. This approach per-
mits—for the first time to our knowledge—rare hM conformers to
be unequivocally detected. We postulate that these conformers, or
their precursors, may mediate the primary event in the patholog-
ical cascade leading to amyloid fiber formation and concomitant
neurodegenerative disease. On the basis of these findings, we
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propose the self-explanatory term ‘‘proteinoscleroses’’ to collec-
tively refer to amyloid-related neurodegenerative diseases. In this
context, hM conformers (or their earliest precursors, if we assume
a sequential pathway) constitute ideal pharmacological targets and
biomarkers of the propensity to develop such diseases. Moreover,
the conformational inhibitor QBP1 appears to target the pathway
that leads to hM conformer formation in expanded polyQs, a-
synuclein, and Sup35NM prion.
Whereas there is evidence for rapid interconversion of
conformers in NPs [21], we propose that once formed, the hM
conformers are likely to be kinetically trapped (because of the high
energy unfolding barriers) and might mechanically jam the
unfoldases of the protein-processing machinery of the cell as
postulated previously [51]. Such an effect would slow down their
processing, which would unbalance the cell proteostasis by
increasing the cytosolic concentration of hM conformers. This
imbalance could affect distinct cellular processes and ultimately, it
may lead to the formation of oligomers and amyloid fibers (Figure
S1). There are three findings that support this hypothesis: (1)
amyloid-related neurodegenerative diseases have a late onset,
developing as aging impairs the efficiency of the protein-processing
machinery [52,53]; (2) the proteasome is transiently impaired in
vivo by the expression of the N-terminus of pathologic huntingtin
[54]; and (3) the AAA+ ATPases from the degradative machines
have recently been shown to unfold their substrates mechanically
using relatively low forces (with a pulling geometry apparently
similar to that of SMFS experiments and a low calculated loading
rate of 0.15 pN/s) [24,25]. Alternatively, toxic NP conformers
may sequester other IDPs involved in essential cell functions [55]
or affect the normal lysosomal autophagy process [56]. It should
also be noted that the causal relationships between misfolding and
oxidative stress remain a matter of debate [57]. In spite of this, it
must be noted that, alternatively, hM conformers may represent
dead-end species, i.e., by-products, off-pathway of amyloidogenesis
and cytotoxicity; in this case the toxic species would be part of the
remaining species of the M pool.
In conclusion, our findings show a clear correlation in all NPs
studied between conformational polymorphism (including the
presence of hM conformers) and neurotoxicity. They strongly
indicate that hM events represent highly collapsed or structured
conformers in the fibrillization pathway and that these conformers,
or their precursors, may be the primary cause of amyloid-related
neurodegenerative diseases. Our approach opens the door to
understanding the molecular mechanism of amyloidogenesis and
developing a single therapeutic strategy that may treat distinct
neurodegenerative diseases using a single drug. Our novel
approach also offers a new means of studying other proteins
involved in conformational diseases and should allow the
dissection (by using the appropriate conditions) of the toxicity
and fibrillogenic pathways involved in amyloidogenesis.
Methods
Polyprotein engineering was performed using a new vector
recently described by our group (pFS-2) (Table S4) [30]. Detailed
methods on polyprotein sample preparation, AFM-SMFS, circular
dichroism (CD), differential scanning calorimetry (DSC), NMR,
turbidimetry, Congo Red binding assay, transmission electron
microscopy (TEM), and imaging AFM experiments can be found
in Text S1.
Supporting Information
Figure S1 Mechanical hypothesis of the primary cause
for amyloid-related neurodegenerative diseases. The use
of the newly developed pFS-2 vector [30] has allowed us to
observe a high degree of conformational polymorphism in
different NPs, comprising conformations with no detectable
mechanical stability (NM conformers, that exhibit no force peaks
in SMFS) and M conformations (with at least one force peak), the
latter including the subset of hM conformers (with at least one
force peak with F$400 pN). As discussed in the main text, it is
reasonable to assume that both M and hM conformers are b-
structured. These different conformers are thought to be in a
highly dynamic equilibrium [21]; however, once formed the hM
conformers may be kinetically trapped by a high unfolding barrier.
We tentatively propose a plausible mechanism of cytotoxicity in
which hM conformers mechanically block the cell’s protein-
processing machinery leading to an increase in their cytosolic
concentration and affecting multiple cellular processes, which
ultimately results in the formation of oligomers and amyloid fibers.
These hM conformers may originate sequentially from less toxic
intermediate b-structured conformations (on-pathway) or they
may trigger the disease through a pathway other than that
proposed here. Alternatively, hM conformers may represent
kinetically trapped by-products of the amyloidogenic/cytotoxic
pathway. The steps blocked by the two inhibitor peptides used in
this study are indicated: QBP1 blocks the conformational change
and displaces the putative RC/b-structure equilibrium towards the
RC conformer (thereby interrupting the pathogenic cascade in its
earliest stages), while SV111 inhibits the oligomerization of the b-
hairpin monomers of Ab42 [38].
(TIF)
Figure S2 Controls for polyQ tract structure and
aggregation in the carrier protein. (A) Far-UV CD spectra
(left) and estimated increase in b-structure content (D%b, relative
to day zero) over the incubation period at 37uC (right). The
features of the CD spectra indicate that the Q19 and Q35 tracts
fused to the I27 carrier remain disordered ([h] = molar ellipticity
per residue). In addition, QBP1 appears to reduce the increase in
the content of b-structure in I27+Q35. (B) 1H NMR. Left,
complete 1D spectra; right, zoom of HN region where
representative resonances of the I27 moiety are labeled [59].
The spectrum of I27-multicloning site (MCS, top) is very similar to
that of the fully folded wt protein [59], and it exhibits the extensive
chemical shift dispersion typical of structured proteins. In the
constructs containing Q19 (middle, red) or Q35 (bottom, green) the
I27-MCS spectrum is retained. Since the 1H chemical shift is
exquisitely sensitive to the local environment, these data are
unequivocal evidence that the native backbone structure is
maintained when the carrier hosts the MCS, Q19, or Q35. Rather
sharp peaks appear in the variants containing Q19 or Q35. These
signals can be assigned to glutamine residue resonances: backbone
HN, 8.4 ppm; sidechain H2N, 7.50 and 6.84; Ha, 4.3; Hc, 2.3;
Hb, 2.1; and Hb9, 2.0 ppm. The sharpness of these signals and the
similarity of the chemical shift values to the reference values for
glutamine in an RC conformation [60] indicate that these polyQ
segments are disordered when grafted in I27. CD and NMR
experiments were not carried out for I27+Q62 because of the
difficulty in producing the protein in the required concentration,
although it must be noted that both I27+Q35 (used for our CD
experiments) and I27+Q62 showed equivalent fibrillogenic behav-
ior when followed by TEM (see below). (C) Aggregation of polyQ
samples over the incubation period at 37uC monitored by
turbidimetry at 405 nm. Only the I27+Q35 and I27+Q62 samples
aggregated. QBP1 inhibits the aggregation of I27+Q62, as
described previously for the Q62 tract fused to thioredoxin [5].
(D) TEM images of I27+Q19 (1), I27+Q35 (2), I27+Q62 (3), and
I27+Q62+QBP1 (4), all after a 32-d incubation at 37uC. The
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protein concentration was 12 mM while that of QBP1 was 20 mM.
No amyloid fibers were observed in I27+Q19 and I27+Q62+QBP1
samples. The images were acquired at 30,0006 (panels 1, 4) and
60,0006 (panels 2, 3). Scale bars correspond to 0.6 (panels 1, 4)
and 0.3 mm (panels 2, 3).
(TIF)
Figure S3 Controls for VAMP2 structure and aggrega-
tion in the carrier protein. (A) Far-UV CD spectra (left), and
estimated increase in b-structure content over the incubation time
at 37uC (right). Considering that the experimental uncertainty is
about 1% Db, no significant increase in b-structure over time was
observed for any of these proteins. (B) 1H NMR. The VAMP2
spectrum (middle, blue) shows resonances whose chemical shift
values and line widths, and lack of signals (right), are hallmarks of a
RC. In the spectrum of the carrier-guest (bottom, red), signal
broadening and retention of native-like I27 signals were observed,
indicating that I27 remains folded while VAMP2 is still
disordered. An additional 2D 1H NOESY spectrum (not shown)
allowed us to assign unambiguously backbone amide, aliphatic,
aromatic, and hydroxyl proton resonances arising from the tertiary
structure of I27 and to definitively corroborate that I27 can adopt
its native folded structure when hosted VAMP2. In this spectrum,
no NOEs between I27 and VAMP2 could be unambiguously
identified (data not shown), suggesting the lack of interaction
between both proteins in the construct. (C) As expected, given the
non-amyloidogenic nature of this IDP, VAMP2 did not aggregate
under any of the conditions studied [35]. (D) TEM images of the
I27-MCS (1), ubi-MCS (2), VAMP2 (3), and I27+VAMP2 (4)
samples, used as negative controls for fibrillogenesis over 30-d
incubation at 37uC. The protein concentration was 40 mM. None
of these samples formed amyloid fibers and, instead, the images
revealed clumps of amorphous aggregates. Images were acquired
at 30,0006 and the scale bars correspond to 0.6 mm.
(TIF)
Figure S4 Controls for Ab42 structure and aggregation
in the carrier protein. (A) Far-UV CD spectra (left), and
estimated increase in b-structure content during the incubation
time at 37uC (right). Moreover, F19S/L34P Ab42 does not
undergo structural transitions, upon incubation at 37uC, and the
presence of the QBP1 and SV111 peptides do not appear to affect
this process (right, in close agreement with our SMFS results,
Figure 3). (B) 1H NMR spectroscopy. Signals of the native I27
carrier (top, black) are retained with only slight shifts in the
variants bearing the Ab42 (red), Arc Ab42 (green), and F19S/
L34P Ab42 (bottom, dark red) grafts indicating that the I27 carrier
retains its native, folded structure. Signals around 8.5–8.0, 7.3–7.0,
and 0.9 ppm increase in size in the presence of the guests, in line
with previous observations that are consistent with hydrogens of
amide, aromatic and methyl groups of Ab42, respectively, in a
predominantly RC conformation [61,62]. (C) Aggregation of
I27+Ab42 samples over the incubation period at 37uC. The
presence of QBP1 does not appear to affect the aggregation of
Ab42. By contrast, the SV111 peptide does inhibit the aggregation
of I27+Ab42, as previously reported for isolated Ab42 [38]. F19S/
L34P Ab42 contains two point mutations reported to impede
Ab42 aggregation [39] and, accordingly, it does not aggregate in
our experimental conditions. (D) TEM images of the I27+Ab42
(1), I27+Arc Ab42 (2), I27+Arc Ab42+QBP1 (3),
I27+Ab42+SV111 (4), I27+F19S/L34P Ab42 (5), Ab42 (6), and
Ab42+QBP1 (7) samples after 32 d at 37uC, except for 6 and 7
whose images were taken after 13-d incubation. The protein,
QBP1 and SV111 concentrations were 10, 20, and 100 mM,
respectively, except for images 6 and 7, where the concentration of
the Ab42 protein alone corresponds to 50 mM while the
concentration of QBP1 (7) was 500 mM. These observations
closely reflect the expected results. No amyloid fibers were
observed in the presence of SV111 or for F19S/L34P Ab42,
while QBP1 appeared to have no effect on the amyloidogenic
capability of Ab42 (even at high concentrations). Images were
acquired at 30,0006 (1, 4), 50,0006 (2), 40,0006 (3), 20,0006 (5–
7). Scale bars correspond to 0.6 (1, 4), 0.35 (2), 0.45 (3), and
0.9 mm (5–7).
(TIF)
Figure S5 Controls for a-synuclein structure and aggre-
gation in the carrier protein. (A) Far-UV CD spectra (left),
and estimated increase in b-structure content during the
incubation at 37uC (right). The ubiquitin module shows a typical
a/b spectrum [63], a-synuclein proteins present characteristic RC
spectra [64]. The carrier-guest protein spectra fairly agree with the
addition of carrier and guest spectra weighted by the relative
contribution of respective sequences to the fusion protein (not
shown). This indicates that a-synuclein inserted into ubiquitin
remains essentially disordered. In the presence of a membrane
mimetic, SDS, a-synuclein as a guest within the ubiquitin carrier
also appears to adopt a highly a-helical conformation as previously
detected by CD and NMR [9]. Accordingly, we found that a-
synuclein and ubi+a-synuclein showed a-helical structure in the
presence of 1 mM SDS. When isolated or as a guest with
ubiquitin, a-synucleins acquire b-structure, during incubation at
37uC, an effect that is suppressed or slowed down by the presence
of QBP1 (right). (B) The 1H NMR spectra of A53T a-synuclein
(blue) and ubi+A53T a-synuclein (red) are largely comparable,
except for very slight changes (mainly at ,1 ppm and ,8 ppm).
This indicates that the behavior of A53T a-synuclein is similar
when isolated or inserted into ubiquitin and no strong interactions
occur between the two proteins in the carrier-guest protein.
Furthermore, the chemical shift values of the resonances in the
upfield region in the 1H NMR spectra for ubi+MCS (black) and
ubi+A53T a-synuclein (red) are very similar. Since these values are
exquisitely sensitive to local environment, this similarity is
conclusive evidence that the hydrophobic core packing in
ubiquitin is unaffected by the presence of the A53T a-synuclein
guest. In the spectrum, the broader lines of ubiquitin carrying the
A53T a-synuclein guest relative to ubi+MCS are consistent with
the larger size and slower tumbling of the former (right). A53T a-
synuclein lacks the upfield signals and its complete 1H spectrum is
typical of a RC. The residues assigned correspond to the folded
ubiquitin structure [65]. Furthermore, crosspeaks between ali-
phatic and aromatic protons, such as Phe45 and Ile61 or Tyr59
and Leu50, are observed in the 2D 1H NOESY spectrum (data not
shown), indicating that the fold of ubiquitin is maintained when it
hosts a-synuclein. Thus, the spectra indicate that the two fused
proteins maintain a high degree of structural integrity. (C)
Aggregation of a-synuclein samples monitored by turbidimetry
at 405 nm. The a-synuclein–containing proteins (isolated or fused
to the ubiquitin carrier module) aggregated while the isolated
carrier module did not. Addition of QBP1 appears to reduce the
aggregation of ubi+A53T a-synuclein, although to a lesser extent
than that of Q62 (Figure S2C). (D) 1–4: TEM images of A53T a-
synuclein (1), ubi+A53T a-synuclein (2, 4), and ubi+A53T a-
synuclein+QBP1 (3) after 22 d at 37uC. The amyloid fibers
observed for A53T a-synuclein and ubi+A53T a-synuclein were
closely comparable. Protein concentration was 10 mM and QBP1
concentration was 20 mM. No fibers were observed for ubi+A53T
a-synuclein+QBP1. Images were acquired at 60,0006 (1),
40,0006 (2), 30,0006(3), and 120,0006 (4). Scale bars correspond
to 0.3, 0.45, 0.6, and 0.15 mm, respectively. 5: AFM image in
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liquid of ubi+A53T a-synuclein after 52 d at 37uC, acquired using
the dynamic mode as described previously [66]. Scale bar
corresponds to 50 nm.
(TIF)
Figure S6 Controls for Sup35NM structure and aggre-
gation in the carrier protein. (A) Far-UV CD spectra (left),
and estimated increase in b-structure content during the
incubation at 37uC (right). The CD spectra indicate that the
Sup35NM prion remains disordered when fused to the I27 carrier
module (the CD spectrum of I27+Sup35NM closely resembles the
sum of I27 and Sup35NM spectra weighted by the relative
contribution of their respective sequences to the fusion protein).
Whereas the spectrum at 5 d (inset) shows features indicating that
RC conformations are still predominant, spectral analysis reveals a
significant increase in b-structure (right panel). Remarkably, the
CD spectrum at 5 d has lost the majority of its intensity, possibly
because of oligomerization and the formation of insoluble
aggregates (see [C]). QBP1 (20 mM) appears to suppress these
oligomerization processes and to reduce the formation of b-
structure. Apparently, I27+Sup35NM acquires more b-structure
than the isolated Sup35NM. This could be attributed to the
positioning of the NP termini in close proximity when it is nested
within I27, which might encourage the formation of contacts. (B)
The 1H NMR spectra of I27-MCS (black), Sup35NM (blue), and
I27+Sup35NM (red) are shown on the left with an expanded view
of the HN resonances on the right. The line broadening of the
I27+Sup35NM spectrum is more evident than that observed for
the other carrier-guest proteins examined (Figures S2B, S3B, S4B,
S5B), probably due to this being the largest guest studied (which is
in a RC conformation) and/or the formation of the oligomers and
aggregates inferred by CD (A). Therefore, to confirm that the
native structure of the I27 carrier is maintained, a 2D 1H NOESY
spectrum was recorded. In this spectrum, signals arising from the
packing of aliphatic and aromatic groups in the native hydropho-
bic core of I27 were observed and rigorously assigned, thus
allowing us to conclude that the native conformation of I27 is still
compatible with the Sup35NM graft (data not shown). (C)
Aggregation of Sup35NM samples. Sup35NM, either isolated or
fused to the I27 carrier, aggregated over the incubation period at
37uC. The presence of QBP1 impedes (or at least reduces)
aggregation of Sup35NM. (D) TEM images of Sup35NM (1),
Sup35NM+QBP1 (2), I27+Sup35NM (3), I27+Sup35NM+QBP1
(4), Sup35NM (6), I27+Sup35NM (7), and pFS-2+Sup35NM (8).
Samples for panels 1–4 were observed after a 32-d incubation at
37uC, while samples for panels 6–8 were incubated for 29 d at
4uC. The concentrations of pFS-2 polyprotein, carrier-guest
protein, guest protein, and QBP1 were 20, 10, 10, and 20 mM,
respectively. The presence of amyloid fibers was reduced by QBP1
peptide, both in Sup35NM (2) and I27+Sup35NM (4) samples,
although fibers remained visible. Amyloid formation was reduced
at 4uC (the temperature used for protein storage before SMFS
experiments). Although still visible, the number of fibers formed by
pFS-2+Sup35NM (8) were considerably less than Sup35NM (6) or
I27+Sup35NM (7) at the same conditions. The TEM images were
acquired at 60,0006 (1, 2), 40,0006 (3), 30,0006 (4), 100,0006
(6), 120,0006 (7), and 80,0006 (8). The AFM image (5) was
acquired using the dynamic mode in liquid as described previously
[66]. Scale bars correspond to 0.3 (1, 2), 0.45 (3), 0.6 (4), 0.5 (5),
0.18 (6), 0.15 (7), and 0.22 (8) mm.
(TIF)
Figure S7 Congo Red binding assay. Concentration (mM) of
Congo Red dye bound to the amyloid aggregates formed by
representative NPs (upper panel), as calculated through the
bathochromic and hyperchromic shifts undergone by the dye
upon specific binding to amyloid aggregates [39]. Isolated
Sup35NM was used as a positive control for these measurements.
The bottom panel shows an optical fluorescence micrograph taken
with a 636 objective showing amyloid aggregates formed by
I27+Sup35NM bound to Congo Red.
(TIF)
Figure S8 Standard heteropolyprotein approach (in
series) for the nanomechanical analysis of polyQ tracts.
(A) Cartoon representing the heteropolyprotein strategy used in
this analysis: (I27)4-Qn-(I27)3. This strategy is conceptually similar
to that recently used for the nanomechanical analysis of a-
synuclein [26]. Two lysine residues were placed flanking the polyQ
tracts to enhance the solubility of the heteropolyproteins [67]. (B)
SMFS spectra of the indicated polyproteins. The left traces show
typical recordings of a NM conformation for the polyQ tracts (in
orange) while several possible M conformers of the protein (I27)4-
Q51-(I27)3 are shown on the right (in red). However, as these force
peaks lie in the frequently contaminated proximal region of the
recordings, one cannot unequivocally demonstrate that they
originate from true M conformers of the NP monomer [45]. (C)
Turbidimetry of (I27)4-Qn-(I27)3 samples, monitored by absor-
bance at 405 nm over the incubation period at 37uC. The lack of
turbidity suggests an inability to aggregate [5]. (D) TEM image of
(I27)4-Q51-(I27)3 after 28 d at 37uC (left). Proteins were used at a
concentration of 10 mM and no fibers were observed. The image
was acquired at 30,0006 and the scale bar corresponds to 1 mm.
AFM image of (I27)4-Q51-(I27)3 incubated for 30 d at 37uC (right)
in which no amyloid fibers were observed. The image was
acquired using the dynamic mode in liquid conditions as described
previously [66]. Scale bar corresponds to 0.5 mm.
(TIF)
Figure S9 Thermodynamic stability of the carrier
protein upon insertion of the guest. (A) Thermal denatur-
ation parameters derived by CD spectroscopy assuming a two-
state (N«D) equilibrium model with pre- and post-transition
baselines linearly depending upon temperature [68]. The half
transition temperature (Tm) and the van’t Hoff enthalpy change
(DHvH) were directly derived from fitting while the entropy change
of unfolding (DS) was calculated using the Gibbs equation [69].
The change in the conformational stability relative to the I27-
MCS variant (DDG) was estimated using the following equation:
DDG&DS:DTm,
where DTm is the difference in the Tm value for a variant relative
to I27-MCS [70]. The DS value used was 193 cal?mol21?K21,
which is the mean value for all the variants. (B) Differential
scanning calorimetry (DSC) curves of indicated proteins and
summary of the denaturation parameters (Tmexp is the T-value at
Cpmax; DHexp the enthalpy change estimated by integration of the
DSC curve; Tm, DHcal, and DHvH the half transition temperature,
and the calorimetric and the van’t Hoff enthalpy changes
estimated from the endotherm deconvolution; and DTh–h the
curve width at half-height). Insertion of A30P or A53T a-synuclein
into the ubiquitin carrier significantly increases the denaturation
enthalpy when compared to insertion of the wt a-synuclein.
Moreover, the ratio between DHcal and DHvH is above unity,
suggesting a tendency towards intermediate formation during
unfolding. This effect disappears upon the addition of an excess
(50 mM) of QBP1 to ubi+A53T a-synuclein samples, which then
unfold following the two-state denaturation model.
(TIF)
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Figure S10 Lack of correlation between F and DLc.
Scatter plots show that there is no correlation between F and DLc
values for: (A) polyQ tracts, (B) Ab42, (C) a-synuclein, and (D)
Sup35NM proteins. No clustering in these plots was observed for
any of the NPs studied, strongly suggesting that no specific regions
in the NPs mediate their mechanical stability. Furthermore,
treatment of samples with QBP1/SV111 peptides did not result in
the loss of any specific population of DLc data points. In principle,
this observation prevents us from extracting any structural
information regarding the mechanism of QBP1 and SV111
binding to NPs.
(TIF)
Figure S11 Effect of familial-disease mutations and
QBP1 on the number of structured regions per molecule.
The average number of force peaks per molecule is shown for: (A)
polyQ tracts; (B) Ab42; (C) a-synuclein; and (D) Sup35NM
proteins. NM conformations correspond to 0 force peaks. These
events are excluded from the average calculations shown in the
figure. The familial-disease mutations increase the number of force
peaks per molecule, suggesting that they increase the propensity to
acquire M structures. By contrast, QBP1 reduces this number for
Q62 and Arc Ab42 but not for A53T a-synuclein or Sup35NM.
Additional controls are required to test if these average differences
are significant. SV111 does not reduce this number in Ab42.
(TIF)
Figure S12 Putative additional hM events. (A) Example of
an event considered as a putative hM. In gray we show the force
peak due to the unfolding of the carrier module (C) and a region of
the NP that is shorter than its full length. The DLc value associated
with this force peak is larger than that of a normal ubiquitin repeat
but not as large as that expected if the entire NP was stretched. To
explain these frequent events, we assume that the polyprotein
attachments (either from the tip or the substrate) were not
maintained until the end of the experiment (i.e., the polyprotein
molecule may have detached before reaching the forces required
to fully unfold the region trapped [28]). Therefore, it is reasonable
to assume that its mechanical stability would be higher than the
force of detachment (last peak in the spectrum, indicated by the
arrow). (B–E) Force of detachment values for the recordings
considered to contain putative additional events for polyQ tracts,
Ab42, a-synuclein, and Sup35NM, respectively. Putative hM
events (with detachment forces $400 pN) are shown in black. This
analysis suggests that the population of hM conformers observed
directly in our study represents an under-estimate of the actual
propensity of the NPs to form these conformers. Thus, it appears
that SMFS experiments miss a considerable fraction of hM
conformers owing to the experimental approach, which seems to
filter out several hM events. These data were not included in our
sample size (n). In (B–E) each vertical bar represents a single event
(one molecule). Note that Q62+QBP1 and Sup35NM+QBP1
yielded no putative hM events and therefore are not represented
here.
(TIF)
Figure S13 Intrinsic disorder predictions for the fusion
polyproteins/proteins used in the study. PONDR values
below 0.5 indicate a tendency to form ordered structures, while
those over 0.5 indicate a tendency for disorder. PONDR VLXT
and PONDR VL3 data are shown as red and blue lines,
respectively. (A) pFS-2 (left) and pFS-2/I27 (I27 as the carrier
protein, right): these predictions show a reasonable correlation
with the proteins contained in the pFS polyproteins, where the
disordered region corresponds to the N2B stretch while the
ordered regions correspond to the I27/ubi repeats (Figure 1A,
[30]). (B) I27-MCS (left) and ubi-MCS (right). (C–G) NPs/
VAMP2 alone (top, guest) and carrier-guest proteins (bottom), as
indicated in the figure. The corresponding guest sequences are
shaded yellow in all plots. Scales for guest and carrier/guest
predictions were normalized such that the region of interest is
same length in both plots. The ends of the regions sharing
common sequences were located in the same x position to facilitate
data comparison of guest and carrier/guest proteins. As Q35 and
Q62 start at the same position in both constructs ([C] top and
bottom) but are of different lengths, the corresponding NP shading
starts at the same position but extends differently. The first yellow
shaded area corresponds to Q19, while Q35 extends to the end of
the grey shaded region and Q62 to the end of the second yellow
shaded zone. The non-shaded region in the guest plots
corresponds to different residues in the protein used, which do
not belong to the guest sequence (i.e., purification tags and
residues added in polyQ expansions [71]). PONDR VLXT and
VL3 use different parameters and window sizes, and were trained
on very different datasets; as a result, their predictions differ
considerably, especially for longer NPs ([F] a-synuclein and [G]
Sup35NM). Nonetheless, all the NPs (except polyQ tracts, as
discussed in Text S1) contain segments that are predicted to be
ordered, in agreement with our SMFS data. Our results suggest
that the structured regions predicted here must be small and
fluctuating to be compatible with the overall RC behavior
observed in CD/NMR (Figures S2, S3, S4, S5, S6).
(TIF)
Table S1 Summary of controls for structure, aggrega-
tion, and fibrillogenesis of the NP. Experiments were carried
out with the carrier-guest proteins alone (unless otherwise stated).
ND, not determined; +, positive result; 2, negative result.
Abbreviations for the techniques are provided in the text. iAFM,
imaging AFM. QBP1 and SV111 are inhibitors referred to in the
main text and described in the Text S1 supplementary methods
section.
(DOC)
Table S2 Mechanical stability (F) of the carrier proteins
upon insertion of guest proteins. The F-values of the carriers
reveal a significant decrease in their mechanical stability upon
insertion of the guest proteins (both in the NM or M
conformations) when compared to the carriers alone
(204626 pN for I27 [72] and 203635 for Ubi [73], at comparable
pulling speeds). This appears to indicate that the guest protein
affects the mechanical stability of the carriers. Considering that
our criteria for selection of SMFS recordings imply the observation
of the force peak for the carrier unfolding, our SMFS data may be
an underestimation (Table 1). SD, standard deviation.
(DOC)
Table S3 Putative M events and number of events per
molecule. # peaks/molecule, average number of M regions
(force peaks) per molecule. The values reported are calculated
considering only M conformers, excluding those monomers
exhibiting a NM conformation (which result in 0 force peaks;
see Figure S11). Error calculations are explained in the Text S1
supplementary methods.
(DOC)
Table S4 Summary of the oligonucleotides used to
design the I27 carrier module and for the cloning of
NPs. The restriction sites introduced by PCR into the amplified
sequences are highlighted in italics. Mutagenic oligonucleotides
are indicated by (Mut) and the mutations introduced are
highlighted in italics and bold. The extra sequences added to the
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terminus of each restriction site were chosen on the basis of
recommendations from New England Biolabs, which enhance the
digestion efficiency of linear DNA sequences. All oligonucleotides
used were purchased from Sigma-Aldrich.
(DOC)
Text S1 Supplementary results, discussion, methods,
and references.
(DOC)
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